Gül-Klein, S.; Schmitz, P.; Schöning, W.; Öllinger, R.; Lurje, G.; Jonas, S.; Uluk, D.; Pelzer, U.; Tacke, F.; Schmelzle, M.;
et al. The Role of Immunosuppression for Recurrent Cholangiocellular Carcinoma after Liver Transplantation. Cancers 2022, 14, 2890.
https://doi.org/10.3390/cancers14122890
AMA Style
Gül-Klein S, Schmitz P, Schöning W, Öllinger R, Lurje G, Jonas S, Uluk D, Pelzer U, Tacke F, Schmelzle M,
et al. The Role of Immunosuppression for Recurrent Cholangiocellular Carcinoma after Liver Transplantation. Cancers. 2022; 14(12):2890.
https://doi.org/10.3390/cancers14122890
Chicago/Turabian Style
Gül-Klein, Safak, Paulina Schmitz, Wenzel Schöning, Robert Öllinger, Georg Lurje, Sven Jonas, Deniz Uluk, Uwe Pelzer, Frank Tacke, Moritz Schmelzle,
and et al. 2022. "The Role of Immunosuppression for Recurrent Cholangiocellular Carcinoma after Liver Transplantation" Cancers 14, no. 12: 2890.
https://doi.org/10.3390/cancers14122890
APA Style
Gül-Klein, S., Schmitz, P., Schöning, W., Öllinger, R., Lurje, G., Jonas, S., Uluk, D., Pelzer, U., Tacke, F., Schmelzle, M., Pratschke, J., Ossami Saidy, R. R., & Eurich, D.
(2022). The Role of Immunosuppression for Recurrent Cholangiocellular Carcinoma after Liver Transplantation. Cancers, 14(12), 2890.
https://doi.org/10.3390/cancers14122890